Skip to main content
. Author manuscript; available in PMC: 2014 Feb 21.
Published in final edited form as: Oncogene. 2013 Feb 25;33(8):1006–1016. doi: 10.1038/onc.2013.31

Table 2.

CD84 expression

patient age m/f zap70 doubling time (month) previous chemotherapy RAI stage autoimmune phenomena lymphocyte count (103/ml) serum IgG(mg/dl) Fold of CD84 (PCR) Fold of CD84 (FCS)
1 82 f positive 7 month none i no 30 <700 2.9
2 34 m negative none I no 40 >700 2.7 6.1
3 75 f nd 12 month none 0 no 30 >700 2.9
4 55 f nd 6 month 0 no 20 700 2.1
5 70 f negative not reached none 0 no 12.5 <700 2.24
6 80 f negative 12 month none 0/I no 140 <700 2.1
7 m positive 3 month FCR II no 40 <700 2.7 4
8 78 m negative 1 month FCR, L/P IV no 46 <700 2.83 5.24
9 58 f positive not reached COP IV coombs pos 150 >700 2.64
10 72 m positive 2 month CHOP-likeIV IV no 80 <700 3.12
11 86 f positive not reached none II no 57 >700 1.4
12 52 m positive 6 month none 0 no 12 >700 1.48
13 53 m negative not reached FC/R IV yes 45 <700 1.16
14 72 f 6 month none 0 no 40 >700 1.57
15 76 f positive 2 month CP, FC/R IV no 120 <700 1.6 4.89
16 72 m negative 6 month L/P III–IV no 40 >700 1.6
17 70 m positive not reached L/P IV no 15 1500 1.48
18 77 m positive 3 month COP III AIHA 80 700 6.68
19 72 f not reached none 0 no 40 >700 5.24
20 34 m negative none I no 40 >700 5.44
21 80 m positive 5 month COP, FCR IV no 6 <700 5.72
22 40 f negative none 0 no 6.34
23 54 m positive 2 month FCR I no 30 >700 4.55
24 70 f not reached none I no 12 >700 6
25 74 m positive FC I no 5.58
26 75 f positive 12 month none 0 no 40 <700 4.9
27 80 f negative 6 month CP IV no 80 <700 5.65
28 61 m FC III no 5.8
29 66 f positive FCR III–IV no 4.96
30 65 m negative 1 year none I no 20 700 6